| Description: |
CD45 MicroBeads were developed for the positive selection or depletion of leukocytes from peripheral blood, erythrocyte and thrombocyte preparations, lymphoid tissues, as well as nonhematopoietic tissues. |
| Application: |
CD45 MicroBeads have diverse applications in research and clinical settings. They have been utilized to enrich fetal erythroblasts from maternal blood and to isolate epithelial tumor cells from peripheral blood, bone marrow, or lymphoid tissue through depletion of CD45+ leukocytes. Additionally, these MicroBeads have been instrumental in enriching stem cells from human bone marrow by depleting cells labeled with CD235a (Glycophorin A) MicroBeads alongside CD45 MicroBeads. In xenogeneic engraftment studies, CD45 MicroBeads are employed for the isolation of CD45+ leukocytes. |
| Product Format: |
CD45 MicroBeads, human are supplied in buffer containing stabilizer and 0.05% sodium azide |
| Storage: |
Store protected from light at +2 to +8°C. Do not freeze. The expiration date is indicated on the vial label. |
| Components: |
2 mL CD45 MicroBeads, human: MicroBeads conjugated to monoclonal antihuman CD45 antibodies (isotype: mouse IgG2a). |
| Capacity: |
For 109 total cells, up to 100 separations. |
| Columns: |
For positive selection: MS, LS, XS, or autoMACS Columns. For depletion: LD, D, or autoMACS Columns. |
